Tim Friede's Blood Aids Antivenom Research

Tim Friede, a Wisconsin resident, has spent nearly two decades self-immunizing against snake venom through self-inflicted bites and injections. His unique immunity has attracted the attention of scientists, particularly Peter Kwong at Columbia University. A study published in Cell (journal) revealed that Friede's blood contains two antibodies capable of neutralizing venom from multiple snake species. This discovery offers a promising path toward developing a broad-protection antivenom, which is currently expensive and species-specific. While the research is in its early stages, tested only in mice and years away from human trials, it represents a significant advancement in addressing the 110,000 annual snakebite deaths reported by the World Health Organization. Tim Friede is now employed by Centivax, a company actively working to develop this new treatment.